UPDATE : Friday, January 17, 2020
BioMarin seeks license for gene therapy to treat hemophilia
The world might be one step closer to the eradication of hemophilia.BioMari...
by Kim Yun-mi  |  2020-01-06 16:44
Lunit raises ₩30 billion in Series C funding
Lunit said that it has attracted investment of 30 billion won ($25.6 millio...
by Lee Han-soo  |  2020-01-06 15:07
‘62% of healthcare workers exposed to violence’
Patients or guardians attack physicians not only in Korea but all over the ...
by Song Soo-youn  |  2020-01-06 15:07
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo  |  2020-01-06 14:40
Tau, rather than amyloid, may cause Alzheimer’s disease
After a recent study suggested that researchers advocating the “amyloid hyp...
by Kim Yun-mi  |  2020-01-06 14:13
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im  |  2020-01-03 17:56
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo  |  2020-01-03 17:55
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo  |  2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo  |  2020-01-03 14:57
[New Year Special] Korean healthcare gears up for new decade of global business
This year marks a decade since the Korean healthcare industry began to ente...
by Kwak Sung-sun  |  2020-01-03 14:15
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo  |  2020-01-03 14:14
Daewoong to kick off P3 trial of Nabota in China
Daewoong Pharmaceutical said Tuesday that it held a meeting with Chinese re...
by Lee Han-soo  |  2020-01-02 17:36
[New Year Special] Investors vulnerable to risky biotech business
President Moon Jae-in announced in May that the government would designate ...
by Kim Yun-mi  |  2020-01-02 17:35
[New Year Special] Biotech rookies may shake up market cap rankings
Korean biotech companies, which drove up the buying spree on the Kosdaq mar...
by Jeong Sae-im  |  2020-01-02 14:31
FDA OKs Huons' generic of topic anesthetic injection
Huons said that the U.S. Food and Drug Administration has approved the comp...
by Lee Han-soo  |  2020-01-02 14:30
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
Medytox said that the Ministry of Food and Drug Safety has approved to sell...
by Lee Han-soo  |  2020-01-02 12:12
Medical info kiosk lends a helping hand for foreign patients
It's not easy navigating a foreign city even if the purpose of the visi...
by Lee Han-soo  |  2020-01-01 05:27
Work hour limit reduces trainee doctors’ time to prepare for specialist exam
The law capping the maximum weekly work hours to 80 for trainee doctors has...
by Kwak Sung-sun  |  2019-12-31 13:33
MSD’s monitoring causes stir for alleged violation of physicians’ privacies
For MSD Korea, 2019 was an embarrassing year.The company’s self-assurance p...
by Kim Yun-mi  |  2019-12-31 12:40
Gore agrees to supply artificial blood vessels for children
W.L. Gore & Associates, the sole provider of artificial vessels used in hea...
by Kwak Sung-sun  |  2019-12-31 10:29
Back to Top